• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】20576

【品名】dihydro-2(3H)-furanone

【CA登记号】96-48-0

【 分 子 式 】C4H6O2

【 分 子 量 】86.09044

【元素组成】C 55.81% H 7.02% O 37.17%

与该中间体有关的原料药合成路线共 10 条

合成路线1

该中间体在本合成路线中的序号:(I)

The reaction of gamma-butyrolactone (I) with Br2 and PBr3 at 100 C followed by a treatment with SOCl2 gives 2,4-dibromobutanoyl chloride (II), which is condensed with O-methylhydroxylamine by means of NaOH in CHCl3 yielding N-methoxy-3-bromopyrrolidin-2-one (III). The reaction of (III) with triphenylphosphine (IV) in hot THF affords the triphenylphosphonium salt (V), which is finally condensed with 3,5-di(tert-butyl)-4-hydroxybenzaldehyde (VI) by means of triethylamine in hot ethanol.

1 Ikuta, H.; Yamagishi, Y.; Akasaka, K.; Yamatsu, I.; Kobayashi, S.; Shirota, H.; Katayamaa, K. (Eisai Co., Ltd.); 2-Pyrrolidone derivatives, process for preparing them, pharmaceutical compositions and use. AU 8656766; EP 0204964; ES 8800148; JP 1986257967; US 4833160 .
2 Shirota, H.; Yamatsu, I.; Yamada, K.; Yomagishi, Y.; Katayama, K.; Kobayashi, S.; Ikuta, H.; Synthesis and antiinflammatory activities of 3-(3,5-di-tert-butyl-4-hydroxybenzylidene)pyrrolidin-2-ones. J Med Chem 1987, 30, 11, 1995.
3 Prous, J.; Castaner, J.; E-5110. Drugs Fut 1989, 14, 4, 307.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
(II) 20577 2,4-dibromobutanoyl chloride C4H5Br2ClO 详情 详情
(III) 20578 3-bromo-1-methoxy-2-pyrrolidinone C5H8BrNO2 详情 详情
(V) 20579 (1-methoxy-2-oxo-3-pyrrolidinyl)(triphenyl)phosphonium bromide C23H23BrNO2P 详情 详情
(VI) 14875 3,5-Bis(1,1-dimethylethyl)-4-hydroxybenzaldehyde; 3,5-di(tert-butyl)-4-hydroxybenzaldehyde; 3,5-Di-tert-butyl-4-hydroxybenzaldehyde 1620-98-0 C15H22O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The condensation of gamma-butyrolactone (I) with phenethyl amine (II) at high temperatures afforded phenethylpyrrolidinone (III). This was alkylated with isobutyl iodide (IV) in the presence of lithium diisopropylamide in cold THF yielding the 3-isobutyl pyrrolidinone (V), and further alkylated with tert-butyl bromoacetate (VI) to give (VII). Subsequent alkylation of (VII) at the alpha-position of carboxylate group with allyl bromide provided (VIII). Ozonolysis of the double bond of (VIII), followed by reductive treatment with NaBH4 produced alcohol (IX), which was coupled with dibenzyl iminodicarboxylate (X) under Mitsunobu conditions giving (XI). The biscarbamate (XI) was deprotected by hydrogenolysis over Pd/C, and the resulting primary amine (XII) was condensed with 3,4-difluorobenzoyl chloride (XIII) to furnish amide (XIV). Then, trifluoroacetic acid-promoted cleavage of the tert-butyl ester of (XIV) provided the corresponding carboxylic acid, which was finally coupled with hydroxylamine by means of EDC and HOBt to afford the target hydroxamic acid

1 Jacobsen, E.J. (Pharmacia & Upjohn AB); Hydroxamic acid derivs. for use with the treatment of diseases related to connective tissue degradation. EP 0898562; JP 2000506163; US 5712300; WO 9732846 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
(II) 18333 Phenethylamine; 2-Phenyl-1-ethanamine 64-04-0 C8H11N 详情 详情
(III) 28259 1-phenethyl-2-pyrrolidinone C12H15NO 详情 详情
(IV) 18168 1-iodo-2-methylpropane 513-38-2 C4H9I 详情 详情
(V) 28267 3-isobutyl-1-phenethyl-2-pyrrolidinone C16H23NO 详情 详情
(VI) 17430 2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate 5292-43-3 C6H11BrO2 详情 详情
(VII) 28260 tert-butyl 2-(3-isobutyl-2-oxo-1-phenethyl-3-pyrrolidinyl)acetate C22H33NO3 详情 详情
(VIII) 28261 tert-butyl 2-(3-isobutyl-2-oxo-1-phenethyl-3-pyrrolidinyl)-4-pentenoate C25H37NO3 详情 详情
(IX) 28268 tert-butyl 4-hydroxy-2-(3-isobutyl-2-oxo-1-phenethyl-3-pyrrolidinyl)butanoate C24H37NO4 详情 详情
(X) 28262 1-[[([[(benzyloxy)carbonyl]amino]carbonyl)oxy]methyl]benzene C16H15NO4 详情 详情
(XI) 28263 tert-butyl 4-[bis[(benzyloxy)carbonyl]amino]-2-(3-isobutyl-2-oxo-1-phenethyl-3-pyrrolidinyl)butanoate C40H50N2O7 详情 详情
(XII) 28264 tert-butyl 4-amino-2-(3-isobutyl-2-oxo-1-phenethyl-3-pyrrolidinyl)butanoate C24H38N2O3 详情 详情
(XIII) 28265 3,4-difluorobenzoyl chloride 76903-88-3 C7H3ClF2O 详情 详情
(XIV) 28266 tert-butyl 4-[(3,4-difluorobenzoyl)amino]-2-(3-isobutyl-2-oxo-1-phenethyl-3-pyrrolidinyl)butanoate C31H40F2N2O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

Reaction of 4-chloroaniline (I) with gamma-butyrolactone (II) in a refluxing solution of HCl afforded pyrrolidinone (III). Subsequent carboxylation of (III) with diethyl carbonate in the presence of NaH gave ketoester (IV), which was reduced to alcohol (V) using calcium borohydride in MeOH. Further treatment of (V) with methanesulfonyl chloride and Et3N provided the corresponding mesylate (VI). Methoxyethylpiperazine (IX) was prepared by alkylation of formylpiperazine (VII) with 2-methoxyethyl bromide, followed by acid deprotection of the alkylated formylpiperazine (VIII). Then, condensation of mesylate (VI) with piperazine (IX) provided racemic (X). Finally, resolution with D-tartaric acid in EtOH yielded the target (R)-isomer.

1 Mita, N.; Nagase, H.; Iizuka, H.; Oguchi, T.; Sakai, K.; Horikomi, K.; Miwa, T.; Takahashi, S. (Mitsui Chemicals, Inc.); Pyrrolidinone derivs. and their use as antipsychotic medicaments. EP 0839805; JP 1998182602 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12034 4-Chlorophenylamine; 4-Chloroaniline; p-Chloroaniline 106-47-8 C6H6ClN 详情 详情
(II) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
(III) 27732 1-(4-chlorophenyl)-2-pyrrolidinone 7661-33-8 C10H10ClNO 详情 详情
(IV) 27733 ethyl 1-(4-chlorophenyl)-2-oxo-3-pyrrolidinecarboxylate C13H14ClNO3 详情 详情
(V) 27734 1-(4-chlorophenyl)-3-(hydroxymethyl)-2-pyrrolidinone C11H12ClNO2 详情 详情
(VI) 27735 [1-(4-chlorophenyl)-2-oxo-3-pyrrolidinyl]methyl methanesulfonate C12H14ClNO4S 详情 详情
(VII) 23801 1-piperazinecarbaldehyde; N-Formylpiperazine 7755-92-2 C5H10N2O 详情 详情
(VIII) 27736 4-(2-methoxyethyl)-1-piperazinecarbaldehyde C8H16N2O2 详情 详情
(IX) 27737 1-(2-methoxyethyl)piperazine C7H16N2O 详情 详情
(X) 27738 1-(4-chlorophenyl)-3-[[4-(2-methoxyethyl)-1-piperazinyl]methyl]-2-pyrrolidinone C18H26ClN3O2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(V)

Coupling of ethyl phenylsulfinylfluoro acetate (I) with bromo derivative (II) by means of NaH in DMF yields ethyl hexenoate (III), which is then oxidized by means of Jones reagent in acetone to provide 5-carboxy pentenoate derivative (IV). Alternatively, compound (IV) can be obtained as follows: eduction of gamma-butyrolactone (V) in THF with aluminum diisobutylhydride in toluene affords gamma-butyrolactol (VI), which is treated with ethyl (diethoxyphosphoryl)fluoroacetate (VII) and sodium bis(trimethylsilyl)amide in THF to provide an isomeric mixture of hexenoates (VIII). O-Protection of (VIII) by means of tert-butyldiphenylchlorosilane and imidazole in DMF followed by chromatographic separation of the geometrical isomers furnishes hexenoate (Z)-(IX), which is finally oxidized with Jones reagent in acetone. Conversion of carboxylic acid (IV) into bicycle (±)-(X) is then performed by first reaction with oxalyl chloride in refluxing hexane to form the corresponding acid chloride, followed by treatment with diazomethane in ether and subsequent reaction with cooper(II) bis(N-tert-butylsalicylaldiimidate) in refluxing benzene. Treatment of oxobicycle (±)-(X) with LiHMDS and chlorotrimethylsilane in THF followed by reaction with palladium acetate in acetonitrile gives 6-fluoro-2-oxobicyclo[3.1.0]hex-3-en-6-carboxylate (±)-(XI), from which epoxide (±)-(XII) is obtained by reaction in toluene with tert-butyl hydroxyperoxide (TBHP) and benzyltrimethylammoniumhydroxide (Triton B) in MeOH or EtOH. Epoxide reduction of (±)-(XII) using diphenyl diselenide (PhSe)2 and sodium borohydride in the presence of HOAc in EtOH, or by means of (PhSe)2, N-acetyl-L-cysteine and sodium tetraborate decahydrate in H2O:EtOH, yields hydroxy derivative (±)-(XIII), which is converted into ethylenedithio derivative (±)-(XV) by first protection of the hydroxyl group with tert-butyldimethylsilyl chloride in DMF in the presence of imidazole, followed by thioketalization with 1,2-ethanedithiol (XIV) and boron trifluoride-diethylether complex in CHCl3 (with subsequent TBS group removal during work-up). Oxidation of the hydroxyl group of (±)-(XV) with DMSO and dicyclohexylcarbodiimide (DCC) in the presence of pyridine and TFA gives ketone (±)-(XVI), which is then hydrolyzed with NaOH in EtOH and subjected to reaction with KCN and ammonium carbonate (Bucherer-Bergs conditions) to yield hydantoin (±)-(XVII). Coupling of (±)-(XVII) with (R)-(+)-1-phenylethylamine using EDC-HCl and HOBt followed by chromatographic separation of the two resulting diastereomers furnishes (1R,2S,5R,6S)-(XIX), which is finally converted into the desired product after hydrolysis with H2SO4.

4 Kumagai, T.; Sakagami, K.; Nakazato, A.; Tomisawa, K. (Taisho Pharmaceutical Co., Ltd.); 6-Fluorobicyclo[3.1.0]hexane derivs.. EP 1110943; JP 2000336071; WO 0012464 .
1 Nakazato, A.; et al.; Synthesis, SAR, and biological activities of potent and selective group II mGluR agonists, novel 2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 104.
2 Nakazato, A.; et al.; Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylix acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists. J Med Chem 2000, 43, 25, 4893.
3 Yoshikawa, R.; Kumagai, T.; Suzuki, Y.; Nakazato, A.; Sakagami, K.; Chaki, S.; Okuyama, S.; Synthesis SAR and biological activities of potent and selective group II metabotropic glutamate receptor antagonists, novel 2-amino-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PB-104.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(rac)-(XIV) 27313 1,2-ethanedithiol 540-63-6 C2H6S2 详情 详情
(rac)-(X) 49005 ethyl (rac)-(1S*,5S*,6S*)-6-fluoro-2-oxobicyclo[3.1.0]hexane-6-carboxylate C9H11FO3 详情 详情
(rac)-(XI) 49006 ethyl (rac)-(1S*,5S*,6S*)-6-fluoro-4-oxobicyclo[3.1.0]hex-2-ene-6-carboxylate C9H9FO3 详情 详情
(rac)-(XII) 49007 ethyl (rac)-(1R*,2S*,4S*,6S*,7S*)-7-fluoro-5-oxo-3-oxatricyclo[4.1.0.0(2,4)]heptane-7-carboxylate C9H9FO4 详情 详情
(rac)-(XIII) 49008 ethyl (rac)-(1R*,2R*,5S*,6S*)-6-fluoro-2-hydroxy-4-oxobicyclo[3.1.0]hexane-6-carboxylate C9H11FO4 详情 详情
(rac)-(XV) 49009   C11H15FO3S2 详情 详情
(rac)-(XVI) 49010   C11H13FO3S2 详情 详情
(rac)-(XVII) 49011   C11H11FN2O4S2 详情 详情
(VIIIa) 49014 ethyl (Z)-2-fluoro-6-hydroxy-2-hexenoate C8H13FO3 详情 详情
(VIIIIb) 49015 ethyl (E)-2-fluoro-6-hydroxy-2-hexenoate C8H13FO3 详情 详情
(I) 49002 ethyl 2-fluoro-2-(phenylsulfinyl)acetate C10H11FO3S 详情 详情
(II) 29460 2-(4-bromobutoxy)tetrahydro-2H-pyran; 4-bromobutyl tetrahydro-2H-pyran-2-yl ether C9H17BrO2 详情 详情
(III) 49003 ethyl (Z)-2-fluoro-6-(tetrahydro-2H-pyran-2-yloxy)-2-hexenoate C13H21FO4 详情 详情
(IV) 49004 (Z)-6-ethoxy-5-fluoro-6-oxo-4-hexenoic acid C8H11FO4 详情 详情
(V) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
(VI) 49013 tetrahydro-2-furanol C4H8O2 详情 详情
(VII) 18192 ethyl 2-(diethoxyphosphoryl)-2-fluoroacetate 2356-16-3 C8H16FO5P 详情 详情
(IX) 49016 ethyl (Z)-6-[[tert-butyl(diphenyl)silyl]oxy]-2-fluoro-2-hexenoate C24H31FO3Si 详情 详情
(XVIII) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(XIX) 49012   C19H20FN3O3S2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

Acetophenone (I) is condensed with gamma-butyrolactone (II) in the presence of NaOMe to afford compound (III), which is finally treated with BF3·Et2O and amine (IV) in dichloromethane/ether. Alternatively, the target compound can be synthesized by regioselective bromination of (III) with PBr3 in dichloromethane to yield bromo derivative (V) followed by heating with primary amine (IV) in MeOH. (Under forceful conditions (V) can be converted into intermediate (VI), which by heating in MeOH in the presence of primary amine (IV) can also lead to the desired product).

1 Batra, S.; et al.; Syntheses and biological evaluation of 3-substituted amino-1-aryl-6-hydroxy-hex-2-ene-1-ones as antioxidant and hypolipidemic agents. Bioorg Med Chem 2000, 8, 8, 2195.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12685 4-Chloroacetophenone; 1-(4-Chlorophenyl)-1-ethanone; p-Chloroacetophenone 99-91-2 C8H7ClO 详情 详情
(II) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
(III) 45873 (Z)-1-(4-chlorophenyl)-3,6-dihydroxy-2-hexen-1-one C12H13ClO3 详情 详情
(IV) 12420 N-(2-Aminoethyl)-N,N-diethylamine; N,N-Diethylethylene-diamine; N(1),N(1)-Diethyl-1,2-ethanediamine 100-36-7 C6H16N2 详情 详情
(V) 45874 (Z)-6-bromo-1-(4-chlorophenyl)-3-hydroxy-2-hexen-1-one C12H12BrClO2 详情 详情
(VI) 45875 1-(4-chlorophenyl)-2-dihydro-2(3H)-furanylidene-1-ethanone C12H11ClO2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

Treatment of gamma-butyrolactone (I) with N,O-dimethylhydroxylamine in the presence of dimethylaluminium chloride afforded the corresponding Weinreb amide (II), which was converted to the keto-alcohol (III) by addition of pentylmagnesium bromide. Swern oxidation of alcohol (III), followed by Wittig reaction of the resultant aldehyde (IV) with (methoxycarbonylmethylene)triphenylphosphorane (V), provided the unsaturated keto ester (VI). Subsequent scandium triflate-mediated peroxyhemiacetalyzation of ketone (VI) gave rise to (VII). Then, intramolecular Michael addition of the hydroperoxy ester (VII) in the presence of diethylamine generated the target cyclic peroxide.

1 Murakami, N.; Horii, T.; Itagaki, S.; Kobayashi, M.; Kawanishi, M.; New readily accessible peroxides with high anti-malarial potency. Bioorg Med Chem Lett 2002, 12, 1, 69.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
(II) 59681 4-hydroxy-N-methoxy-N-methylbutanamide C6H13NO3 详情 详情
(III) 59682 1-hydroxy-4-nonanone C9H18O2 详情 详情
(IV) 59683 4-oxononanal C9H16O2 详情 详情
(V) 14689 Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate 2605-67-6 C21H19O2P 详情 详情
(VI) 59684 methyl (E)-6-oxo-2-undecenoate C12H20O3 详情 详情
(VII) 59685 methyl (E)-6-hydroperoxy-6-methoxy-2-undecenoate C13H24O5 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

Dimethylaluminium chloride-catalyzed ring opening of butyrolactone (I) with N,O-dimethylhydroxylamine furnishes the N-methoxy amide (II). Subsequent condensation of the Weinreb amide (II) with pentylmagnesium bromide (III) gives rise to the hydroxy ketone (IV). Further oxidation of the primary alcohol function of (IV) under Swern conditions leads to keto aldehyde (V). Then, Wittig condensation of aldehyde (V) with (methoxycarbonylmethylene) triphenylphosphorane (VI) affords the unsaturated ester (VII). Treatment of (VII) with urea-hydrogen peroxide in the presence of scandium triflate generates the hydroperoxide compound (VIII), which undergoes further intramolecular ring closure in the presence of triethylamine, leading to the 1,2-dioxane (IX). Enzymatic hydrolysis of ester (IX) employing pig liver esterase gives acid (X). After activation of (X) as the corresponding pentafluorophenyl ester (XI), condensation with propylamine in pyridine provides the title N-propyl amide

1 Murakami, N.; Kawanishi, M.; Mostaqul, H.M.; Tsuruta, K.; Itagaki, S.; Horii, T.; Kobayashi, M.; Exploitation for new antimalarials using spongean peroxides as scaffolds. 22nd Symp Med Chem (Nov 27 2002, Shizuoka) 2002, Abst 1P-12.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
(II) 59681 4-hydroxy-N-methoxy-N-methylbutanamide C6H13NO3 详情 详情
(III) 31871 bromo(pentyl)magnesium 693-25-4 C5H11BrMg 详情 详情
(IV) 59682 1-hydroxy-4-nonanone C9H18O2 详情 详情
(V) 59683 4-oxononanal C9H16O2 详情 详情
(VI) 14689 Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate 2605-67-6 C21H19O2P 详情 详情
(VII) 59684 methyl (E)-6-oxo-2-undecenoate C12H20O3 详情 详情
(VIII) 59685 methyl (E)-6-hydroperoxy-6-methoxy-2-undecenoate C13H24O5 详情 详情
(IX) 60083 methyl 2-(6-methoxy-6-pentyl-1,2-dioxan-3-yl)acetate C13H24O5 详情 详情
(X) 60084 2-(6-methoxy-6-pentyl-1,2-dioxan-3-yl)acetic acid C12H22O5 详情 详情
(XI) 60085 2,3,4,5,6-pentafluorophenyl 2-(6-methoxy-6-pentyl-1,2-dioxan-3-yl)acetate C18H21F5O5 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

 

1 王海京,高国强,羽易.2005. 1,4一丁二醇脱氢制备(一丁内脂的方法. 发明专利申请公开说明书,CN 1590382
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 43160 1,4-butanediol;1,4-Dihydroxybutane;1,4-Butylene glycol;Tetramethylene glycol 110-63-4 C4H10O2 详情 详情
(II) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情

合成路线9

该中间体在本合成路线中的序号:(II)

 

1 沈伟,扬新艳,徐华龙.2005.一种γ-丁内脂的倦化合成方法.发明专利申请公开说明书,CN 1687045
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 43160 1,4-butanediol;1,4-Dihydroxybutane;1,4-Butylene glycol;Tetramethylene glycol 110-63-4 C4H10O2 详情 详情
(II) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情

合成路线10

该中间体在本合成路线中的序号:(II)

 

1 Zeng Yi, Wang Gongying. 2004. Study on catalyst and process for producing γ-butyrolactone from l,4-butanediol dehydrogenation. 化学工业与工程技术,25(5): 5~7
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 43160 1,4-butanediol;1,4-Dihydroxybutane;1,4-Butylene glycol;Tetramethylene glycol 110-63-4 C4H10O2 详情 详情
(II) 20576 dihydro-2(3H)-furanone 96-48-0 C4H6O2 详情 详情
Extended Information